Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$126.43 - $145.6 $31 Million - $35.7 Million
245,000 New
245,000 $35.7 Million
Q1 2022

May 16, 2022

SELL
$108.42 - $129.58 $61.2 Million - $73.1 Million
-564,300 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$115.43 - $146.63 $11.1 Million - $14.1 Million
-96,500 Reduced 14.6%
564,300 $71.7 Million
Q3 2021

Nov 15, 2021

BUY
$136.35 - $158.76 $90.1 Million - $105 Million
660,800 New
660,800 $96.7 Million
Q1 2020

May 15, 2020

SELL
$78.28 - $155.73 $14 Million - $27.8 Million
-178,700 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$127.4 - $146.83 $22.8 Million - $26.2 Million
178,700 New
178,700 $26.7 Million
Q4 2017

Feb 14, 2018

SELL
$105.55 - $120.83 $5.17 Million - $5.92 Million
-49,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $5.24 Million - $5.77 Million
49,000
49,000 $5.74 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.